← Back to Clinical Trials
Recruiting NCT05839756

NCT05839756 Predicting Post Extubation Stridor After Maxillomandibular Fixation

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05839756
Status Recruiting
Phase —
Sponsor Mansoura University
Condition Stridor
Study Type INTERVENTIONAL
Enrollment 62 participants
Start Date 2023-05-03
Primary Completion 2028-02-25

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
budesonidenormal saline

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 62 participants in total. It began in 2023-05-03 with a primary completion date of 2028-02-25.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Endotracheal intubation can induce laryngotracheal injury which results in narrowing of the airway due to edema of the glottis. This can increase the risk of development of post-extubation stridor (PES)

Eligibility Criteria

Inclusion Criteria: * Adult patients (\>18 years) * American Society of Anesthesiologists status I and II * undergoing elective maxillomandibular fixation surgeries under general anesthesia with nasal endotracheal intubation Exclusion Criteria: * patients' refusal * pregnant females * patients with body mass index \<18.5 or ≥ 35 kg/m2 * risk of aspiration * cardiorespiratory disorder * neuromuscular disease * uncontrolled diabetes mellitus * gastrointestinal bleeding * on chronic steroid therapy * intubated patients or were intubated or had upper airway infection within 1 week prior to surgery * history of any pathology, radiotherapy or surgery in the neck * had difficult laryngeal US plane (as neck wound)

Contact & Investigator

Central Contact

Maha A AboZeid, MD

✉ mahazed@yahoo.com

📞 02-01019216192

Frequently Asked Questions

Who can join the NCT05839756 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Stridor. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05839756 currently recruiting?

Yes, NCT05839756 is actively recruiting participants. Contact the research team at mahazed@yahoo.com for enrollment information.

Where is the NCT05839756 trial being conducted?

This trial is being conducted at Al Mansurah, Egypt.

Who is sponsoring the NCT05839756 clinical trial?

NCT05839756 is sponsored by Mansoura University. The trial plans to enroll 62 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology